Paul Tudor Jones's MRVI Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 396,915 shares of Maravai LifeSciences Holdings, Inc. (MRVI) worth $1.12 M, representing 0.00% of the portfolio. First purchased in 2020-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in MRVI for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 396,915 shares. Largest reduction occurred in Q1 2021, reducing 174,735 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Maravai LifeSciences Holdings (MRVI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Maravai LifeSciences Holdings (MRVI) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +396,915 | New Buy | 396,915 | $2.83 |
| Q1 2021 | -174,735 | Sold Out | 0 | $0.00 |
| Q4 2020 | +174,735 | New Buy | 174,735 | $28.05 |
Paul Tudor Jones's Maravai LifeSciences Holdings Investment FAQs
Paul Tudor Jones first purchased Maravai LifeSciences Holdings, Inc. (MRVI) in Q4 2020, acquiring 174,735 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Maravai LifeSciences Holdings, Inc. (MRVI) for 3 quarters since Q4 2020.
Paul Tudor Jones's largest addition to Maravai LifeSciences Holdings, Inc. (MRVI) was in Q1 2026, adding 396,915 shares worth $1.12 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 396,915 shares of Maravai LifeSciences Holdings, Inc. (MRVI), valued at approximately $1.12 M.
As of the Q1 2026 filing, Maravai LifeSciences Holdings, Inc. (MRVI) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Maravai LifeSciences Holdings, Inc. (MRVI) was 396,915 shares, as reported at the end of Q1 2026.